News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,036 Results
Type
Article (39303)
Company Profile (247)
Press Release (651486)
Section
Business (203984)
Career Advice (2002)
Deals (35399)
Drug Delivery (89)
Drug Development (80917)
Employer Resources (169)
FDA (16122)
Job Trends (14820)
News (344802)
Policy (32467)
Tag
Academia (2531)
Alliances (49290)
Alzheimer's disease (1300)
Approvals (16091)
Artificial intelligence (183)
Bankruptcy (354)
Best Places to Work (11624)
Biotechnology (175)
Breast cancer (216)
Cancer (1603)
Cardiovascular disease (123)
Career advice (1668)
Cell therapy (324)
Clinical research (65075)
Collaboration (615)
Compensation (332)
COVID-19 (2556)
C-suite (142)
Data (1518)
Diabetes (197)
Diagnostics (6238)
Earnings (85149)
Employer resources (146)
Events (110572)
Executive appointments (529)
FDA (16948)
Funding (559)
Gene therapy (224)
GLP-1 (636)
Government (4351)
Healthcare (18743)
Infectious disease (2658)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16427)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7878)
Lung cancer (238)
Manufacturing (223)
Medical device (13246)
Medtech (13251)
Mergers & acquisitions (19289)
Metabolic disorders (518)
Neuroscience (1686)
NextGen: Class of 2025 (6508)
Non-profit (4474)
Northern California (1941)
Obesity (294)
Opinion (190)
Parkinson's disease (113)
Patents (138)
People (56733)
Phase I (20262)
Phase II (28662)
Phase III (21347)
Pipeline (648)
Postmarket research (2562)
Preclinical (8563)
Radiopharmaceuticals (240)
Rare diseases (304)
Real estate (5894)
Regulatory (21839)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1679)
Startups (3567)
United States (17395)
Vaccines (596)
Weight loss (201)
Date
Today (134)
Last 7 days (600)
Last 30 days (2805)
Last 365 days (34748)
2025 (2924)
2024 (35217)
2023 (40078)
2022 (51174)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (715)
Arizona (206)
Asia (37440)
Australia (6119)
California (4446)
Canada (1621)
China (371)
Colorado (202)
Connecticut (211)
Europe (80219)
Florida (645)
Georgia (156)
Illinois (439)
Indiana (249)
Maryland (703)
Massachusetts (3426)
Michigan (190)
Minnesota (325)
New Jersey (1260)
New York (1279)
North Carolina (804)
Northern California (1941)
Ohio (164)
Pennsylvania (1039)
South America (1093)
Southern California (1679)
Texas (647)
Utah (131)
Washington State (440)
691,036 Results for "apollon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Apollon and MIT Commence Collaboration to Develop Continuous Non-Invasive Glucose Monitoring Technology
Apollon Inc. , a medtech startup based in Seoul, will collaborate with the Laser Biomedical Research Center (LBRC) at the Massachusetts Institute of Technology (MIT) with the aim of developing and conducting clinical trials of non-invasive CGMs using Raman spectroscopy for the next two years.
August 21, 2023
·
2 min read
Global Hemp Group Adds Israel, the European Union and Morocco as Exclusive Global Licenses from Apollon Formularies, PLC
GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) (“GHG” or the “Company”) announces that the Company has now added additional exclusive global licenses for the countries of Israel, and the European Union (with extension to Morocco) from Apollon Formularies, plc.
March 21, 2023
·
3 min read
Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property
GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) (“GHG” or the “Company”) is pleased to announce that it has completed its contractual obligations relating to the first stage of the binding Letter of Intent (“LOI”)
April 4, 2023
·
4 min read
Business
Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways
Apollon Formularies plc and Aion Therapeutic Inc. are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells
May 18, 2021
·
11 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 3, 2025
·
1 min read
Press Releases
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
·
8 min read
1 of 69,104
Next
